StockSelector.com
  Research, Select, & Monitor Monday, December 10, 2018 11:00:57 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Tandem Diabetes Care, Inc.$34.09$.601.79%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Tandem Diabetes Care, Inc. has an overall rank of 2255 out of 7466 stocks based on 8 positive rankings and 4 negative rankings.

Positive Rankings
Historic Revenue Growth
Tandem Diabetes Care rank is 59
Positive Guidance
Within the past 90 days Tandem Diabetes Care has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Target Prices
The average analysts' target price is $56.00 for Tandem Diabetes Care using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Tandem Diabetes Care is ranked 203.
90 Day Gain
Tandem Diabetes Care rank is 323
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Tandem Diabetes Care is ranked 353.
10 Day Gain
Tandem Diabetes Care rank is 846
Up EPS Surprise
Tandem Diabetes Care beat the consensus earnings estimate when it last reported quarterly earnings.
Low Put/Call
Tandem Diabetes Care has a low Put/Call ratio of 0.51 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Tandem Diabetes Care is ranked 1360.
Negative Rankings
Negative ROA
Tandem Diabetes Care rank is 371
Price-to-Sales
Tandem Diabetes Care rank is 386
Negative Net Margin
Tandem Diabetes Care rank is 645
High vPut/Call
Tandem Diabetes Care has a high Put/Call ratio of 0.99 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Tandem Diabetes Care is ranked 1516.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.